Berberine
Also known as: Berberine hydrochloride · Coptis chinensis · Huang lian · Berberis
A golden plant alkaloid from traditional Chinese and Ayurvedic medicine that supports gut barrier integrity and a balanced microbiome.
Emerging research. Consistent benefit in laboratory colitis models, and a completed human safety trial in ulcerative colitis. Efficacy studies in Crohn’s are still to come.
Emerging research. Pre-clinical / mechanistic rationale — human trials pending. The science is compelling but still early, which is exactly why real-world experience from our community matters.
Affiliate disclosure: We may earn a commission on recommended products, at no extra cost to you. Learn more
How it works
Berberine activates AMPK, the cell’s master energy sensor, which in turn helps moderate NF-κB and MAPK inflammatory signalling. In colitis research it supports tight-junction proteins that seal the gut lining, helps balance Th17 and regulatory T cells, and reshapes the gut microbiome. Because very little berberine is absorbed into the bloodstream, most of it stays in the gut — right where it is needed for gut-focused support.
Traditional use
Berberine-rich plants such as goldenseal, Coptis (huang lian) and barberry have been used for thousands of years in traditional Chinese and Ayurvedic medicine, especially for diarrhoea, dysentery and digestive complaints.
Highlights
- Supports gut barrier integrity and a balanced microbiome in colitis research across multiple laboratories.
- Completed a randomised Phase I human trial in ulcerative colitis alongside mesalamine.
- Also supports healthy blood sugar — useful for people dealing with steroid-related glucose changes.
- Mostly stays in the gut rather than entering circulation, concentrating its activity where it matters.
- Can affect how some medications are metabolised, so share it with your care team.
What the research shows
Every study below links to its original publication so you can read it yourself. Many natural compounds have only been studied in small trials. That isn’t a verdict on them; it reflects how little funding exists for compounds that can’t be patented.
| Study | Design & population | Outcome |
|---|---|---|
| Xu 2020 Mixed result | Randomised, double-blind, placebo-controlled Phase I safety trial, 3 months 16 patients randomised 3:1 · Clinically stable ulcerative colitis on maintenance mesalamine | Primary objective was safety. One grade 3 transaminase elevation and one grade 1 nausea among 12 on berberine; none among 4 on placebo. |
Randomised, double-blind, placebo-controlled Phase I safety trial, 3 months · 16 patients randomised 3:1 · Clinically stable ulcerative colitis on maintenance mesalamine
Primary objective was safety. One grade 3 transaminase elevation and one grade 1 nausea among 12 on berberine; none among 4 on placebo.
Using it alongside conventional care
Berberine has a long traditional history for digestive complaints and is increasingly popular among people exploring natural approaches to gut health. Its human IBD research so far is a safety trial run alongside Mesalamine, and larger efficacy studies are the next step. Two practical points make it relevant to conventional care. It supports healthy blood-sugar metabolism, which many people value during Prednisone courses. It is also a strong inhibitor of drug-metabolising enzymes, so it can raise levels of thiopurines and other medications — share it with your gastroenterologist and pharmacist, particularly if you take Stelara, Humira or Azathioprine.
Medications mentioned
Humira (adalimumab)
Anti-TNF biologic
Neutralises tumour necrosis factor alpha (TNF-α), a master cytokine driving intestinal inflammation.
Stelara (ustekinumab)
IL-12/23 inhibitor
Blocks the shared p40 subunit of interleukin-12 and interleukin-23.
Prednisone (prednisone / prednisolone)
Corticosteroid
Broad transcriptional suppression of inflammatory gene programmes.
Mesalamine (mesalazine / 5-ASA)
Aminosalicylate
Topically acting anti-inflammatory at the mucosal surface.
Never stop or change a prescribed medication without your gastroenterologist. Many people use natural support alongside conventional care, and your care team can help you do that safely.
Recommended sourcing
Where to buyWhat to look for in Berberine
- Berberine HCl with a clearly stated mg per capsule
- Third-party tested (USP, NSF or independent COA)
- Split doses with meals for better tolerance
- Avoid proprietary blends that hide the berberine amount
Studies have used 600–900 mg/day. Not suitable during pregnancy or breastfeeding. Ask about liver-enzyme monitoring.
Shop trusted retailers
Paid links: we may earn a commission when you buy through these links, at no extra cost to you. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Amounts used in research
The ulcerative colitis Phase I trial used 900 mg/day for 3 months. Adenoma prevention trials have used 600 mg/day for up to two years. No Crohn’s-specific dose has been established.
Good to know
- Documented grade 3 transaminase elevation in a small safety trial — liver monitoring is warranted, not optional.
- A potent inhibitor of CYP3A4, CYP2D6 and P-glycoprotein, so it can raise levels of co-administered drugs including thiopurines and tacrolimus. This is the most practically important risk in an IBD population.
- Contraindicated in pregnancy and in neonates — berberine displaces bilirubin from albumin and can cause kernicterus.
- Commonly causes GI upset, cramping and constipation at higher doses.
- Lowers blood glucose, which can compound the effect of diabetes medications.
Community experiences
Reported benefit
Typical dose
Time to notice
Common pairings
Real-world data for Berberine is coming. When our Community Symptom Tracker launches, this section will show anonymised, aggregated experiences from people with Crohn’s who have tried Berberine: how many noticed a difference, what they took, and what they paired it with.
Community data will always be labelled as self-reported, and it won’t replace the published research above.
Coming soon
Tried Berberine? Your experience matters.
Our Community Symptom Tracker will let you log what you take and how you feel — and see what’s working for people like you. Alongside it, our wellness store will offer curated, third-party-tested protocols.
Sources
-
A Phase I trial of berberine in Chinese with ulcerative colitis
Xu L, Zhang Y, Xue X, et al. · Cancer Prevention Research · 2020
-
Li C, Xi Y, Li S, et al. · Molecular Immunology · 2015 · PMID 26210182
Phase 2 — in development
Where traditional research stops, our community begins
Natural compounds can’t be patented, so they rarely get the multi-million-dollar trials that drugs receive. That leaves people with Crohn’s without answers to the questions that matter most: what actually helps, at what dose, and for whom? Our Community Symptom Tracker will crowdsource those answers from real people living with Crohn’s, and our upcoming wellness store will make it easy to find quality, third-party-tested products.
- Log your symptoms, supplements and doses in a private daily tracker
- See what’s working for people with the same disease location and medications
- Contribute to the largest real-world dataset on natural Crohn’s support
- Shop curated, third-party-tested protocols from our upcoming store
Be one of the first to join
Early access is opening soon. Bookmark this page and check back — we’ll announce sign-ups here first.